OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00769059

Kukdo Chemical Co Ltd

Specialty ChemicalsVerified

Kukdo Chemical maintains a debt-to-equity ratio of 0.67, indicating a moderate leverage position relative to its equity base. The company's liquidity position is characterized by a current ratio of 1.49, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Kukdo Chemical reports a return on equity (ROE) of 2.53% and a return on assets (ROA) of 1.25%. These figures are below the typical thresholds for strong performance in the Specialty Chemicals industry, indicating that the company is generating relatively modest returns for its shareholders and asset base. The company's revenue is derived from two primary segments: Epoxy Resin and Polyol Resin. The Epoxy Resin segment focuses on manufacturing and sales of epoxy resins, hardener resins, and reactive diluents, while the Polyol Resin segment deals with polyol resins used in polyurethane production. The geographic exposure is primarily concentrated in Korea, with no significant international revenue diversification disclosed. Looking at the growth trajectory, Kukdo Chemical's capital expenditures for the period were -42,788,280,280 KRW, indicating a reduction in investment in long-term assets. This may suggest a strategic shift or a focus on cost optimization rather than expansion. The company's free cash flow of 27,634,155,120 KRW provides some flexibility for reinvestment or shareholder returns. The risk assessment for Kukdo Chemical highlights a medium liquidity risk and a low dilution risk. The company's debt structure, with long-term debt of 576,162,318,980 KRW, and its equity base of 861,872,271,400 KRW, suggests a balanced capital structure. However, the negative net cash position after debt is a concern for liquidity. Recent events and disclosures do not indicate any significant changes in the company's operations or financial strategy. Analysts have provided a mean price target of 54,000 KRW with a strong buy recommendation, reflecting confidence in the company's future performance.

30-day price · 007690+3150.00 (+8.9%)
Low$34750.00High$44450.00Close$38350.00As of15 May, 00:00 UTC
Profile
CompanyKukdo Chemical Co Ltd
Ticker007690.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Kukdo Chemical Co Ltd is a Korea-based company primarily engaged in the manufacturing and sales of epoxy resins and polyol resins, which are used in electrical and electronic, paints, civil engineering, and adhesives fields.

Classification. Kukdo Chemical is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Kukdo Chemical maintains a debt-to-equity ratio of 0.67, indicating a moderate leverage position relative to its equity base. The company's liquidity position is characterized by a current ratio of 1.49, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Kukdo Chemical reports a return on equity (ROE) of 2.53% and a return on assets (ROA) of 1.25%. These figures are below the typical thresholds for strong performance in the Specialty Chemicals industry, indicating that the company is generating relatively modest returns for its shareholders and asset base. The company's revenue is derived from two primary segments: Epoxy Resin and Polyol Resin. The Epoxy Resin segment focuses on manufacturing and sales of epoxy resins, hardener resins, and reactive diluents, while the Polyol Resin segment deals with polyol resins used in polyurethane production. The geographic exposure is primarily concentrated in Korea, with no significant international revenue diversification disclosed. Looking at the growth trajectory, Kukdo Chemical's capital expenditures for the period were -42,788,280,280 KRW, indicating a reduction in investment in long-term assets. This may suggest a strategic shift or a focus on cost optimization rather than expansion. The company's free cash flow of 27,634,155,120 KRW provides some flexibility for reinvestment or shareholder returns. The risk assessment for Kukdo Chemical highlights a medium liquidity risk and a low dilution risk. The company's debt structure, with long-term debt of 576,162,318,980 KRW, and its equity base of 861,872,271,400 KRW, suggests a balanced capital structure. However, the negative net cash position after debt is a concern for liquidity. Recent events and disclosures do not indicate any significant changes in the company's operations or financial strategy. Analysts have provided a mean price target of 54,000 KRW with a strong buy recommendation, reflecting confidence in the company's future performance.
Key takeaways
  • Kukdo Chemical maintains a moderate leverage position with a debt-to-equity ratio of 0.67.
  • The company's ROE of 2.53% and ROA of 1.25% indicate modest returns for shareholders and assets.
  • Revenue is concentrated in two segments, with no significant international diversification.
  • Free cash flow of 27,634,155,120 KRW provides flexibility for reinvestment or shareholder returns.
  • Analysts have provided a strong buy recommendation with a mean price target of 54,000 KRW.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$1.40T
Gross profit$235.54B
Operating income$52.44B
Net income$21.80B
R&D
SG&A
D&A
SBC
Operating cash flow$9.04B
CapEx-$42.79B
Free cash flow$27.63B
Total assets$1.75T
Total liabilities$887.63B
Total equity$861.87B
Cash & equivalents$107.59B
Long-term debt$576.16B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.40T$52.44B$21.80B$27.63B
FY-1$1.31T$24.03B$8.84B-$74.77B
FY-2$1.31T$18.04B$7.70B-$50.12B
FY-3$1.60T$96.93B$74.32B-$35.04B
FY-4$1.58T$204.73B$157.70B$100.12B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$1.75T$861.87B$107.59B
FY-1$1.59T$839.73B$59.07B
FY-2$1.51T$834.45B$44.65B
FY-3$1.50T$845.36B$29.39B
FY-4$1.42T$801.04B$40.86B
PeriodOCFCapExFCFSBC
FY0$9.04B-$42.79B$27.63B
FY-1$54.55B-$121.47B-$74.77B
FY-2$114.31B-$86.73B-$50.12B
FY-3$113.45B-$123.14B-$35.04B
FY-4-$25.93B-$79.11B$100.12B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$413.93B
FQ-1$373.26B$12.62B$1.93B$824.8M
FQ-2$354.48B$10.76B$5.80B$11.85B
FQ-3$348.70B$16.15B$8.38B$16.10B
FQ-4$319.11B$12.90B$5.69B-$1.14B
FQ-5$326.48B$6.52B$5.47B-$9.40B
FQ-6$340.12B$5.85B-$598.0M-$26.38B
FQ-7$343.03B$9.92B$4.86B-$15.11B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$863.07B$241.06B
FQ-1$1.75T$861.87B$107.59B
FQ-2$1.75T$854.65B$150.08B
FQ-3$1.62T$836.67B$70.97B
FQ-4$1.69T$840.97B$204.90B
FQ-5$1.59T$839.73B$59.07B
FQ-6$1.68T$822.10B$118.63B
FQ-7$1.65T$836.83B$55.85B
PeriodOCFCapExFCFSBC
FQ0-$3.11B-$9.72B
FQ-1$9.04B-$42.79B$824.8M
FQ-2$22.38B-$28.51B$11.85B
FQ-3$14.52B-$20.40B$16.10B
FQ-4$25.01B-$14.04B-$1.14B
FQ-5$54.55B-$121.47B-$9.40B
FQ-6-$1.48B-$94.60B-$26.38B
FQ-7-$27.54B-$56.56B-$15.11B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$861.87B
Net cash-$468.57B
Current ratio1.5
Debt/Equity0.7
ROA1.2%
ROE2.5%
Cash conversion41.0%
CapEx/Revenue-3.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric007690Activity
Op margin3.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin1.6%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin16.9%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity67.0%59.0% medp25 54.9% · p75 72.9%above median
Observations
IR observations
Mean price target54,000.00 KRW
Median price target54,000.00 KRW
High price target54,000.00 KRW
Low price target54,000.00 KRW
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate4,176.00 KRW
Last actual EPS2,475.00 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-19 08:05 UTC#02215a72
Market quoteclose KRW 36650.00 · shares 0.01B diluted
no public URL
2026-05-18 01:27 UTC#ed16b9b9
Source: analysis-pipeline (hybrid)Generated: 2026-05-19 08:07 UTCJob: 24fdf5c0